Pathogens express a set of proteins required for establishing and maintaining an infection, termed virulence life-style genes (VLGs). Due to their outsized importance in pathogenesis, VLG products are attractive targets for the next generation of antimicrobials.
Introduction
All pathogenic bacteria require virulence life-style genes (VLGs) for survival in the host environment (1). These include both classical virulence factors that are dispensable for growth in rich media and essential genes that modulate pathogenesis (2) . Next generation of sequencing of bacterial transposon mutant libraries (e.g. Tn-Seq (3), INSeq (4)) from infected animals has enabled comprehensive identification of non-essential VLGs in a single experiment, rapidly increasing our knowledge of which genes are required for pathogenesis (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) ). There are two major limitations of Tn-Seq to study VLGs, both arising from the complete loss of function usually caused by Tn-mutagenesis. First, core essential genes are by definition excluded from the analysis of environment-specific essentiality. Secondly, all-or-nothing mutations preclude our ability to observe the relationship between expression of the gene product and fitness in the host environment; this information could be valuable in identifying VLGs for which the organism is highly sensitive to slight perturbation, which would be ideal candidates for inhibitors. Thus, methods that can partially perturb VLG function in the context of pathogenesis are highly valuable.
Gene repression tools that are currently used to study VLGs during infection have provided numerous insights into gene function but have key technical limitations. Antisense RNAs (17, 18) have variable efficacy, substantial off-target effects (19) (20) (21) , and cannot be rationally designed (22) . Methods to trigger protein degradation (i.e., degrons (23) (24) (25) (26) ) require each gene of interest to be tagged at its native locus and suffer from toxicity due to interference with protein function and stability (26) . Gene depletion from inducible promoters also requires insertion of the promoter upstream of all genes of interest and is limited by the inability to optimize both control of non-induced promoter expression (leakiness) and maximal amount of induced gene product (27) .
In contrast, CRISPRi-use of a catalytically-inactive variant of the Cas9 nuclease (dCas9) to repress transcription (28)-is highly efficacious and specific in bacteria (29) , easily programmable by editing the first 20 nt of the guide RNA (sgRNA (30)), does not require modification of the chromosome at each targeted gene, and maintains the native regulation of targeted genes. We previously developed "Mobile-CRISPRi," a technology that enables transfer and stable integration of CRISPRi systems into diverse bacteria (Fig. 1A) (31) . Here, we optimize Mobile-CRISPRi for targeting VLGs in a P. aeruginosa PA14 murine pneumonia model of infection.
Optimized dCas9 expression eliminates toxicity and allows for graded knockdowns dCas9 overexpression often causes non-specific toxicity in bacteria (32) , which would likely complicate the interpretation of our CRISPRi experiments in infection models. Indeed, we found that full induction of an arabinose-inducible promoter (P BAD ) driving the expression of dCas9 variants from Streptococcus pyogenes (dCas9 spy ) (28) or Streptococcus thermophilus (dCas9 sth ) (33) resulted in reduced growth of PA14 in rich culture medium, whereas partial induction showed no apparent toxicity (Fig. 1B) . We reasoned that titrating chemical inducers (e.g. arabinose) in a mouse model could be impractical due to variable tissue penetration (34-38), so we instead focused on expressing dCas9 spy from a series of weak constitutive promoters from the BioBrick Registry (39) to reduce toxicity (Fig. S1 ) and achieve partial knockdown. To assess CRISPRi efficacy using the BioBrick promoter strains, we employed a "test" version of Mobile-CRISPRi expressing monomeric Red Fluorescent Protein (mRFP) and an sgRNA targeting the mRFP gene (31) . Knockdown levels were quantified for each promoter through comparing the mutants' fluorescence normalized to growth over time After 12 hours, we found stable fluorescence ratios between mutants without and with sgRNA (Fig. S2) . The gradient of knockdown from 10-17-fold at the 14-hour time point roughly corresponds to the BioBrick promoter strength used to express dCas9 (Fig. 1C) . We performed RNA-seq on cells expressing dCas9 from the strongest of the three BioBrick promoters in our set and confirmed that CRISPRi retained specificity (Fig. 1D) . We conclude that Mobile-CRISPRi optimized with BioBrick promoters driving dCas9 spy enables a non-toxic gradient of constitutive knockdowns in PA14.
Mobile-CRISPRi targeting of VLGs in a murine pneumonia model
A major goal for developing Mobile-CRISPRi in infection models is to identify VLGs for which a modest perturbation has a substantial impact on pathogenesis. To do so, the system must demonstrate stable repression of the gene of interest over the course of infection. As a test case, we targeted exsA, which encodes the key activator of T3SS genes in P. aeruginosa.
Because the exsA gene is positively autoregulated (40), we reasoned modest knockdown would cause a large reduction in transcription of T3SS genes, resulting in a loss of effector secretion and impaired virulence. Consistent with this, we found that CRISPRi knockdown of exsA reduced expression of T3SS genes by more than 100-fold ( Fig. 2A) , similar to expression levels observed in a strain with an exsA disruption (exsA::Tn (41)). As anticipated, knockdown of a positively autoregulated transcriptional factor suppressed the previously observed promoterdependent gradation. Of note, the high levels of exsA in the exsA::Tn strain is attributed to amplifying the region of the gene upstream of transposon insertion ( Table S3) . Knockdown of exsA also eliminated detectable production of T3SS pilus (PopB/D) and effector (ExoT/U) proteins (Fig. 2B) . Neither the exsA knockdown nor the non-targeting control sgRNA strains showed a growth defect in rich culture medium (Fig. S1) .
Loss of exsA function is known to strongly attenuate virulence in a murine pneumonia model (42, 43) . To test whether Mobile-CRISPRi can be used to probe the functions of VLGs such as exsA in a host environment, we intratracheally instilled C57BL/6 mice with a range of suggesting that non-specific toxicity of dCas9 was mitigated by reduced expression. Other general indicators of infection including hypothermia and leukopenia were observed for the nontargeting and WT controls. These phenotypes were similarly diminished among the exsA targeting strain, exsA disruption strain, and PBS control (Fig. S3) . We conclude that MobileCRISPRi can probe VLG phenotypes in infection models.
Discussion
We previously demonstrated that Mobile-CRISPRi could be used to repress gene expression in a number of bacterial pathogens associated with antibiotic resistance (e.g., the ESKAPE pathogens: Enterococcus, Staphylococcus, Klebsiella, Acinetobacter, Pseudomonas, and
Enterobacter (31, 45) ). Our optimized Mobile-CRISPRi system opens the door to systematic analysis of VLGs in these pathogens during infection, enabling drug-gene interaction studies and, in principle, a screen for new inhibitors that synergize with the host immune system.
Methods

Construction of Mobile-CRISPRi plasmids and strains
Plasmids encoding nuclease-null Streptococcus pyogenes and Streptococcus thermophilus
dCas9s were gifted by Lei Qi and Sarah Fortune, respectively. The vectors containing Tn7-based Mobile-CRISPRi system were constructed as previously described by Peters (31). dCas9
was expressed from arabinose-inducible P BAD promoter and three constitutive promoters:
Anderson BBa_J23117 (P1), Anderson BBa_J23114 (P2) and Anderson BBa_J23115 (P3). The chimeric sgRNA was expressed by a constitutive promoter, P trc with no LacI operator site. In this study, all the mutants were constructed from Pseudomonas aeruginosa UCBPP-PA14 by triparental mating as previously described (31) . A complete list of plasmids and strains used in the study can be found in Supplementary Table 1 
Toxicity measurements
For dCas9 toxicity measurements, WT PA14 and the mutants were streaked on Pseudomonas Isolation Agar (PIA) plates and incubated for 20 hours at 37°C. On the second day, 2 ml LB medium tube containing one colony from each plate were cultured in a shaker incubator at 37°C
and 350 rpm for 12 hours. Then cultures were diluted in 100 μL LB medium with no inducer, 0.1% arabinose, or 1% arabinose to yield a mixture with OD 600nm of 0.05 in a 96-well plate (Cat.
No. 351177, Corning, NY). These were grown with a lid for 9 -10 hours on a plate shaker (OrbiShaker MP, Benchmark Scientific, NJ) at 37°C and 900 rpm. The OD 600nm of the plate cultures were measured every hour using a microplate reader (SpectraMax 340PC, Molecular
Devices, CA).
RFP knockdown efficiency
Following tri-parental mating, two P. aeruginosa colonies were picked from each strain to serve as biological replicates and were incubated overnight in 3 mL of LB + 100 μg/mL gentamicin selective media at 37°C with shaking. These cultures were diluted to .01 OD 600 
RNA extraction
PA14 Mobile-CRISPRi mutants, exsA::Tn7, and WT were streaked onto VBMM or LB agar plates and incubated overnight at 37°C. One colony from each plate was grown in MinS (T3SS-inducing minimal media supplemented with nitrotriacetic acid and lacking calcium medium) (46) or LB medium at 37°C for 16 hours with shaking at 250 rpm. Then the strains were subcultured in 400 µL fresh MinS or LB medium until the OD 600nm reached 1.0. Total RNA was extracted from cell pellets using the RNeasy minikit (Qiagen) according to the manufacturer's instructions with on-column DNase I digestion (Qiagen). The RNA extracts were aliquoted and stored at -80°C.
Quantitative reverse transcriptase PCR (qRT-PCR)
cDNA was synthesized using Random Hexamer primers and RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific; Waltham, MA). To check the amplification efficiency of the primers, 1:50 dilution of WT PA14 cDNA was mixed with "PowerUp SYBR Green Master Mix"
(Thermo Scientific; Waltham, MA) and detected by the MX3000P qPCR System (Stratagene, La Jolla, CA, USA). Primers for T3SS related genes (Table S3) had amplification efficiency between 90%-110%. PA14 housekeeping gene, nadB, was used as internal control for normalization of total RNA levels (47) . The relative efficiency of each primer pair was tested and compared with that of nadB and the threshold cycle data analysis (2 -ΔΔCt ) was used (48) . All reactions were performed in triplicates and repeated at least twice using independent cultures, with average values of biological replicates and error bars representing standard deviation of ΔΔCt.
cDNA library preparation and RNA-Seq
The RNA concentration for each sample was determined with a NanoDrop spectrophotometer (Thermo Fisher Scientific). 10 ng total RNA of each sample was fragmented for 6 min, cDNA libraries were prepared using "NEBNext ® Ultra TM RNA Library Prep Kit for Illumina reads were collected for each of the two samples, with ~94% alignment to PA14 WT by Bowtie2 (49) , and transcripts were counted with HTSeq (50).
Type III Secretion Profile of Pseudomonas aeruginosa by Immunoblotting
To knockdown exsA gene, two specific sgRNAs, exsA1 and exsA2 were designed. PA14
Mobile-CRISPRi mutants, exsA::Tn, and WT were streaked onto VBMM agar plates and incubated at 37°C for overnight. One colony from each plate was grown at 37°C for 16 hours in a shaking incubator at 250 rpm in MinS media (46) . Bacteria were removed by centrifugation at 6000 x g for 15 min. Then the supernatant was collected and the secreted proteins were precipitated by the addition of ammonium sulfate. The protein pellets were dissolved in sample buffer. After boiling, samples were loaded onto ExpressPlus 4-20% PAGE gels (Genscript;
Piscataway, NJ) and run under denaturing conditions. PAGE gels were transferred to PVDF membrane and immunoblotted with polyclonal rabbit antiserum against ExoU, ExoT/ExoS, PopB and PopD proteins as previously described (46) .
Murine Infection Model
Pathogen-free male C57BL/6J mice, 8 weeks of age, were purchased from Jackson
Laboratories. Animal experiments were conducted in accordance with the approval of the Institutional Animal Care and Use Committee (IACUC) at UCSF. 29 mice were randomly assigned in five groups, G1: WT PA14, 6 mice; G2: P3 with sgRNA mRFP, 5 mice; G3: P3 with exsA1 sgRNA, 10 mice; G4: exsA::Tn, 6 mice; G5: saline control, 2 mice. Mice were anesthetized with isofluorane prior to intratracheal instillation with bacteria at a range of 1x10 5 to 1x10 7 CFU/animal in a volume of 50 mL per an established protocol (44) . Animal weights and rectal temperatures were measured prior to euthanasia. The lungs were collected in 1mL of sterile PBS and processed with a handheld homogenizer (Kinematica, Polytron PT1200E). 50 μl of lung homogenate with appropriate dilutions were spread onto PIA plates with and without gentamicin to count output CFU. Bacterial recovery rate was calculated as the ratio of output CFU to input CFU. For whole blood analysis, blood was collected by cardiac puncture into acid citrate dextrose (Sigma-Aldrich), and WBC was measured by hematology analyzer (Genesis, Oxford Science).
Statistical analysis
GraphPad Prism (v. 7.0) was used for the statistical analysis of all the data. P values < 0.05
were considered statistically significant. For the RFP fluorescence assay, Ordinary one-way ANOVA followed by Turkey's multiple comparison test was used to compare OD 600 -normalized median fluorescence values between strains featuring the same promoter with and without sgRNA. Ordinary one-way ANOVA followed by Turkey's multiple comparison test was also used to compare log-transformed bacterial recovery rate, temperature, WBC counts, and weight changes.
